Real-world evidence on psoriasis treatments in China

A Real World Evidence Study in Chinese Psoriasis Patients

This study looks at how well different psoriasis treatments work for patients in China by tracking their progress through a mobile app.

Quick facts

• Study type: Observational
• Enrollment: 10000 (estimated)
• Sex: All
• Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University (Academic / other)
• Locations: 29 sites (Hangzhou, Zhejiang and 28 other locations)
• Trial ID: NCT04465838 on ClinicalTrials.gov

What this trial studies

This observational study gathers real-world data from multiple centers in China to evaluate the effectiveness of various psoriasis treatments chosen by patients themselves, including phototherapy, traditional systemic therapy, and biologics. Patients diagnosed with psoriasis by dermatologists will participate, and their treatment outcomes will be monitored using a mobile application called 'Psoriasis New World'. The primary outcome is the percentage of patients achieving a complete reduction in psoriasis severity, measured by the Psoriasis Area and Severity Index (PASI) and other assessment tools. The study aims to provide insights into treatment effectiveness in a real-world setting without imposing specific treatment protocols.

Who should consider this trial

Good fit: Ideal candidates for this study are patients diagnosed with psoriasis by a dermatologist who are seeking treatment options.

Not a fit: Patients who do not have a diagnosis of psoriasis or those who are not seeking treatment will not benefit from this study.

Why it matters

Potential benefit: If successful, this study could help identify the most effective psoriasis treatments in real-world settings, leading to improved patient outcomes.

How similar studies have performed: Other studies have shown success in evaluating real-world treatment effectiveness for psoriasis, indicating that this approach is both relevant and valuable.

Eligibility criteria

Inclusion Criteria:

* all the patients diagnosed as psoriasis by dermatologist in clinic.

Exclusion Criteria:

* None

Where this trial is running

Hangzhou, Zhejiang and 28 other locations

• Second Affiliated Hospital, School of Medicine, Zhejiang University — Hangzhou, Zhejiang, China (Recruiting)
• Beijing Children's Hospital Affiliated to Capital Medical University — Beijing, China (Recruiting)
• the First Affiliated Hospital of Chongqing Medical University — Chongqing, China (Recruiting)
• the First Affiliated Hospital of Fujian Medical University — Fujian, China (Recruiting)
• General Hospital of Lanzhou Military Region — Gansu, China (Recruiting)
• Sun Yat-sen Memorial Hospital — Guangdong, China (Recruiting)
• The Peoples' Hospital of Guangxi Zhuang Autonomous Region — Guangxi, China (Recruiting)
• the Affiliated Hospital of Guizhou Medical University — Guizhou, China (Recruiting)
• The Fifth People's Hospital of Hainan Province — Hainan, China (Recruiting)
• the First Hospital of Hebei Medical University — Hebei, China (Recruiting)
• the Second Affiliated Hospital of Harbin Medical Unviersity — Heilongjiang, China (Recruiting)
• Henan Provincial Peoples' Hospital — Henan, China (Recruiting)
• the Affiliated Hospital of Inner Mongolia Medical University — Hohhot, China (Recruiting)
• Union Hospital, Tongji Medical College, Huazhong University of Science and Technology — Hubei, China (Recruiting)
• Xiangya Hospital, Central South University — Hunan, China (Recruiting)
• the Second Affiliated Hospital of Nanchang University — Jiangxi, China (Recruiting)
• Yanbian University Hospital — Jilin, China (Recruiting)
• Institute of Dermatology, Chinese Academy of Medical Sciences — Nanjing, China (Recruiting)
• Xining First Hospital — Qinghai, China (Recruiting)
• Shandong Provincial Hospital for Skin Diseases — Shandong, China (Recruiting)
• Shanghai Dermatology Hospital — Shanghai, China (Recruiting)
• Taiyuan Central Hospital — Shanxi, China (Enrolling_by_invitation)
• the Second Affiliated Hospital of Xi'an Jiaotong University — Shanxi, China (Recruiting)
• the First hospital of China Medical University — Shenyang, China (Recruiting)
• Sichuan Provincial People's Hospital — Sichuan, China (Recruiting)
• Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital — Tianjin, China (Recruiting)
• First Affiliated Hospital, School of Medicine, Shihezi University — Xinjiang, China (Recruiting)
• General Hospital of Ningxia Medical University — Yinchuan, China (Recruiting)
• the Second Affiliated Hospital of Kunming Medical University — Yunnan, China (Recruiting)

Study contacts

• Study coordinator: Xiao-yong Man, MD

Conditions Psoriasis